<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/DF3F1419-349B-4A43-BCC5-DF09B4B3441A"><gtr:id>DF3F1419-349B-4A43-BCC5-DF09B4B3441A</gtr:id><gtr:name>Oxford Expression Technologies Limited</gtr:name><gtr:address><gtr:line1>2 CHAWLEY PARK, CUMNOR HILL</gtr:line1><gtr:city>OXFORD</gtr:city><gtr:postCode>OX2 9GG</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DF3F1419-349B-4A43-BCC5-DF09B4B3441A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>DF3F1419-349B-4A43-BCC5-DF09B4B3441A</gtr:id><gtr:name>Oxford Expression Technologies Limited</gtr:name><gtr:address><gtr:line1>2 CHAWLEY PARK, CUMNOR HILL</gtr:line1><gtr:city>OXFORD</gtr:city><gtr:postCode>OX2 9GG</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>185025.0</gtr:offerGrant><gtr:projectCost>264322.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CEB496D0-8DC8-4905-8F65-D1ACDAD75C9B" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>CEB496D0-8DC8-4905-8F65-D1ACDAD75C9B</gtr:id><gtr:name>Oxford Brookes University</gtr:name><gtr:address><gtr:line1>Headington Campus</gtr:line1><gtr:line2>Gipsy Lane</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:line5>Oxfordshire</gtr:line5><gtr:postCode>OX3 0BP</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>90501.0</gtr:offerGrant><gtr:projectCost>90501.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E449451C-DA97-4EA3-812D-F246DB379F59"><gtr:id>E449451C-DA97-4EA3-812D-F246DB379F59</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Possee</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=102731"><gtr:id>EF60DC8F-30FB-422C-9AFF-AE1F45A15D71</gtr:id><gtr:title>Newton Fund - Pretransplant gene therapy of pancreatic islet tissue; towards a therapy for Diabetes type I in Mexico</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>102731</gtr:grantReference><gtr:abstractText>More than 1 million people in Mexico suffer from diabetes mellitus type 1 (DM1), in which pancreatic islet cells

have been damaged so that they cannot make insulin to regulate body glucose levels. Today DM1 is the most

frequent metabolic disorder affecting infants and young people in Mexico. The diabetes has to be treated with

life-long, daily injections of insulin and often leads to serious health complications that affects quality of life.

Pancreatic islet transplantation can reverse the diabetes in these children soon after diagnosis and hence make

an immediate impact on their quality of life; we aim to establish an islet isolation and transplant programme in

Mexico. In addition, an innovative preclinical study will assess the strategy of using stem cell and gene

therapies to enhance the effectiveness and success of islet transplantation programmes in both the UK and

Mexico, and these aim to overcome the current problems associated with islet cellular injury and rejection.

The longer term benefits of the research and innovation programme will be reaslised through the

establishment of a joint UK-Mexico research centre in Mexico City.</gtr:abstractText><gtr:fund><gtr:end>2018-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>275526</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">102731</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>